Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002536010 | SCV000964880 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-12-09 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001293959 | SCV001482671 | uncertain significance | Dyskeratosis congenita, autosomal dominant 2 | 2020-11-18 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV003222148 | SCV003918352 | uncertain significance | not provided | 2022-10-14 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004538131 | SCV004106229 | uncertain significance | TERT-related disorder | 2023-03-28 | criteria provided, single submitter | clinical testing | The TERT c.2813G>A variant is predicted to result in the amino acid substitution p.Arg938Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.015% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-1264549-C-T). It is interpreted as uncertain significance in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/665677/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |